T. Rowe Price Associates
FMI

T. Rowe Price Associates’s Foundation Medicine, Inc. FMI Stock Holding History

T. Rowe Price Associates’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-54,952
Closed -$1.02M – 2582
2016
Q2 		$1.02M Sell
54,952
-18
-0% -$325 ﹤0.01% 1698
2016
Q1 		$999K Buy
54,970
+60
+0.1% +$967 ﹤0.01% 1706
2015
Q4 		$1.16M Hold
54,910
– – ﹤0.01% 1651
2015
Q3 		$1.01M Sell
54,910
-1,657
-3% -$41.4K ﹤0.01% 1703
2015
Q2 		$1.91M Buy
+56,567
New +$2.28M ﹤0.01% 1602
2014
Q3 		– Sell
-44,413
Closed -$1.2M – 2582
2014
Q2 		$1.2M Buy
+44,413
New +$1.13M ﹤0.01% 1684

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates's FMI Position: Q3 2016 in Review

T. Rowe Price Associates sold out of Foundation Medicine, Inc. (FMI) in Q3 2016, closing a stake of 54,952 shares — an estimated $1.02M sold.

T. Rowe Price Associates first reported a position in FMI in Q2 2014 and held it in 6 quarters. The position peaked at $1.91M in Q2 2015. 103 funds tracked by Wall St. Rank hold FMI as of Q3 2016.

  • T. Rowe Price Associates reported no remaining Foundation Medicine, Inc. position as of Q3 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 54,952 Foundation Medicine, Inc. shares in Q3 2016, an estimated $1.02M.
  • T. Rowe Price Associates first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 6 quarters.
  • T. Rowe Price Associates's Foundation Medicine, Inc. position peaked at $1.91M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2016.

Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.